46. Faria, N. R., E. C. Sabino, M. R. Nunes, L. C. Alcantara, N. J. Loman, and O. G. Pybus. “Mobile Real-Time Surveillance of Zika Virus in Brazil.” Genome Medicine 8 (2016): 97.
47. Dudas, G., L. M. Carvalho, T. Bedford, A. J. Tatem, G. Baele, N. R. Faria, D. J. Park, et al. “Virus Genomes Reveal Factors that Spread and Sustained the Ebola Epidemic.” Nature 544 (2017): 309–15.
48. Cohen, J. “Where Has All the Zika Gone?” Science 357 (2017): 631–32.
49. Cohen, J. “Steep Drop in Zika Cases Undermines Vaccine Trial.” Science 361 (2018): 1055–56.
Глава 16 Вирус иммунодефицита человека: СПИД, бич нашего века
1. Groopman, J. “Can AIDS Be Cured?” The New Yorker, December 22, 2014.
2. Jaffe, S. “USA Sets Goal to End the HIV Epidemic in a Decade.” Lancet 393 (2019): 625–26.
3. Corey, L., and G. E. Gray. “Preventing Acquisition of HIV Is the Only Path to an AIDS-Free Generation.” Proceedings of the National Academy of Sciences USA 114 (2017): 3798–3800.
4. Teeraanchai, S., Kerr, S. J., Amin, J. Ruxrungtham, K., Law, M. G. “Life Expectancy of HIV-Positive People After Starting Combination Antiretrovial Therapy: A Meta-Analysis. HIV Medicine 18 (2017): 256–266.
5. Fauci, A. S., and H. D. Marston. “Ending the HIV-AIDS Pandemic-Follow the Science.” New England Journal of Medicine 373 (2015): 2197–99.
6. Cohen, J. “Ending AIDS Movement Falters World Wide.” Science 361 (2018): 438.
7. Justman, J. E., O. Mugurungi, and W. M. El-Sadr. “HIV Population Surveys – Bringing Precision to the Global Response.” New England Journal of Medicine 378 (2018): 1859–61.
8. Cohen, J. “For the First Time in History, Half of All People with HIV Are Getting Treatment.” Science 357 (2017): 336–39.
9. Dabis, F., and L. – G. Bekker. “We Still Need to Beat HIV.” Science 357 (2017): 335.
10. Gallo, R. C. “Shock and Kill with Caution.” Science 354 (2016): 177–78.
11. Sengupta, S., and R. F. Siliciano. “Targeting the Latent Reservoir for HIV-1.” Immunity 48 (2018): 872–95.
12. Mouquet, H. “Hunting Down the HIV-1 Reservoir: A Starring Role for Antibodies?” Immunity 46 (2017): 527–29.
13. Gottlieb, M. S., R. Schroff, H. M. Schanker, J. D. Weisman, P. T. Fan, R. A. Wolf, and A. Saxon. “Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men.” New England Journal of Medicine 305 (1981): 1425–31.
14. Gallo, R. C., P. S. Sarin, E. P. Gelmann, M. Robert-Guroff, E. Richardson, V. S. Kalyanaraman, D. Mann, et al. “Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS).” Science 220 (1983): 865–67.
15. Barré-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Daguet, et al. “Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS).” Science 220 (1983): 868–71.
16. Essex, M., M. F. McLane, T. H. Lee, L. Falk, C. W. Howe, J. I. Mullins, C. Cabradilla, and D. P. Francies. “Antibodies to Cell Membrane Antigens Associated with Human T-Cell Leukemia Virus in Patients with AIDS.” Science 220 (1983): 859–62.
17. Gottlieb, M. S., J. E. Groopman, W. M. Weinstein, J. L. Fahey, and R. Detels. “The Acquired Immunodeficiency Syndrome.” Annals of Internal Medicine 99 (1983): 208–20.
18. Hirsch, M. S., and J. Curran. “Human Immunodeficiency Viruses.” In Fields Virology, 3rd ed., edited by B. N. Fields and D. M. Knipe, 1953–76. Philadelphia: Lippincott-Raven, 1996.
19. Gluckmann, J. C. “AIDS Virus History.” Science 259 (1993): 1809.
20. Gallo, R. Virus Hunting: AIDS, Cancer and the Human Retrovirus. New York: Basic Books, 1991.
21. “Russia’s Burgeoning HIV Epidemic.” Editorial, Lancet 393 (2019): 612.
22. Deeks, S. G., and F. Barre-Sinoussi. “Towards a Cure for HIV.” Nature 487 (2012): 293–94.
23. Cohen, J. “New Estimates Scale Back Scope of HIV/ AIDS Epidemic.” Science 318 (2007): 1360.
24. Нобелевская премия по физиологии или медицине. www.nobelprize/medicine/2018/allison/lecture/.
25. Cox, M. A., R. Nechanitzky, and T. W. Mak. “Check Point Inhibitors as Therapies for Infectious Diseases.” Current Opinion in Immunology 48 (2017): 61–67.
26. Cohen, J. “Did Merck’s Failed HIV Vaccine Cause Harm?” Science 318 (2007): 1048–49.
27. Cohen, J., and B. Lester. “Trials of NIH’s AIDS Vaccine Get a Yellow Light.” Science 318 (2007): 1852.
28. “Cold Shower for AIDS Vaccine.” Editorial, Nature Medicine 13 (2007): 1389.
29. Hsu, D. C., and R. J. O’Connell. “Progress in HIV Vaccine Development.” Human Vaccine Immunotherapy 13 (2017): 1018–30.
30. Excler, J. L., and N. L. Michael. “Lessons from HIV-1 Vaccine Efficacy Trials.” Current Opinion in HIV and AIDS 11 (2016): 607–13.
31. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. “Restoring Function in Exhausted CD8 T Cells During Chronic Viral Infection.” Nature 439 (2006): 682–87.
32. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. “Interleukin-10 Determines Viral Clearance or Persistence in Vivo.” Nature Medicine 12 (2006): 1301–9.
33. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. “Resolution of a Chronic Viral Infection after Interleukin-10 Receptor Blockade.” Journal of Experimental Medicine 203 (2006): 2461–72.
34. Brooks, D. G., A. M. Lee, H. Elsaesser, D. B. McGavern, and M. B. Oldstone. “IL-10 Blockade Facilitates DNA Vaccine-Induced T Cell Responses and Enhances Clearance of Persistent Virus Infection.” Journal of Experimental Medicine 205 (2008): 533–41.
35. Ha, S. J., S. N. Mueller, E. J. Wherry, D. L. Barber, R. D. Aubert, A. H. Sharpe, G. J. Freeman, and R. Ahmed. “Enhancing Therapeutic Vaccination by Blocking PD-1-Mediated Inhibitory Signals During Chronic Infection.” Journal of Experimental Medicine 205 (2008): 543–55.
36. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, et al. “PD-1 Expression on HIV-Specific T Cells Is Associated with T-Cell Exhaustion and Disease Progression.” Nature 443 (2006): 350–54.
37. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. “Reinvigorating Exhausted HIV-Specific T Cells Via PD-1–PD-1 Ligand Blockade.” Journal of Experimental Medicine 203 (2006): 2223–27.
